New York-based Baba has raised $40 million in Series A financing to expand its healthcare coordination platform for Medicare and Medicaid patients.
The round was led by FirstMark Capital, with participation from CVS Health Ventures and Valtruis. Existing investors General Catalyst, Genius Ventures and Ground Up Ventures also participated.
The financing brings Baba's total reported funding to approximately $47 million.
Founded in 2025 by CEO Connor Sweeney, Baba is addressing a problem affecting millions of older Americans: navigating healthcare systems that require patients to coordinate between doctors, insurers, hospitals, pharmacies and social services.
The company combines dedicated human care teams with AI systems designed to reduce the administrative burden of managing complex medical needs.
Each patient is assigned a care team that can include coordinators, licensed therapists and other healthcare professionals.
These teams help arrange appointments, manage care transitions, resolve insurance and billing issues, coordinate transportation and connect patients with relevant support services.
Baba also operates behavioral health services, including access to licensed therapists.
AI is used to support the administrative and coordination work, with the goal of allowing clinical professionals to serve more patients without proportionally increasing operational costs.
The company reports supporting more than 10,000 patients and families across the United States, with more than 100,000 families on its waiting list.
That reach remains small relative to the approximately 70 million Americans enrolled in Medicare, highlighting both the market opportunity and the scale required to address it.
Baba is also developing AI research infrastructure through BabaBench, a benchmark designed to evaluate how AI agents perform complex healthcare advocacy tasks.
Unlike evaluations that test whether a model can answer individual medical questions, BabaBench measures whether agents can complete longer processes involving insurance paperwork, billing, follow-up calls and other administrative tasks while respecting privacy and operational restrictions.
The company says the research has been accepted for presentation at a NeurIPS workshop.
In June 2026, Baba was selected to participate in the Centers for Medicare & Medicaid Services' ACCESS Model, a program testing technology-supported approaches to chronic care.
The company plans to expand relationships with health plans and move toward value-based arrangements, in which compensation can depend partly on patient outcomes and overall healthcare costs.
That represents an important potential evolution from its existing fee-for-service model.
Baba's economic proposition is that better care coordination can prevent costly complications, reduce unnecessary administrative work and improve access to appropriate treatment.
The opportunity is substantial, particularly for patients with multiple chronic conditions who interact with several providers and healthcare systems.
However, healthcare coordination is difficult to scale because many problems require human judgment, licensed professionals and direct intervention.
Baba must demonstrate that AI meaningfully reduces the cost of serving patients without undermining safety or the quality of care.
Its next commercial test is translating patient demand into sustainable contracts with insurers and health systems, supported by measurable improvements in outcomes and healthcare spending.